|
Volumn 55, Issue 7, 1999, Pages 521-525
|
Absorption, metabolism and excretion of a single oral dose of 14C- repaglinide during repaglinide multiple dosing
|
Author keywords
Insulin secretagogue; Repaglinide; Type 2 diabetes
|
Indexed keywords
CARBON 14;
REPAGLINIDE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
DRUG EXCRETION;
DRUG FECES LEVEL;
DRUG METABOLISM;
DRUG TOLERABILITY;
DRUG URINE LEVEL;
ERYTHROCYTE METABOLISM;
HUMAN;
INSULIN RELEASE;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PANCREAS ISLET BETA CELL;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
ABSORPTION;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AREA UNDER CURVE;
CARBAMATES;
CARBON RADIOISOTOPES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ERYTHROCYTES;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
METABOLIC CLEARANCE RATE;
PIPERIDINES;
TIME FACTORS;
TISSUE DISTRIBUTION;
|
EID: 0032830946
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s002280050667 Document Type: Article |
Times cited : (69)
|
References (7)
|